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Summary. New strains of Pseudomonas aeruginosa were isolated from clinical
and environmental settings in order to characterize the virulence properties of this
opportunistic pathogen. P. aeruginosa was frequently recovered from oil-contami-
nated samples but not from non-oil-contaminated soils. The virulence of five envi-
ronmental and five clinical strains of P. aeruginosa was tested using two different
models, Drosophila melanogaster and Lactuca sativa var. capitata L. There was no
difference in the virulence between the two groups of isolates in either of the mod-
els. Since environmental P. aeruginosa strains are used for bioaugmentation in
bioremediation programs, the results presented here should be taken into account
in the future design of degradative consortia and/or in establishing containment
measures. [Int Microbiol 2006; 9(4):247-252]
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Introduction
Pseudomonas aeruginosa is a ubiquitous and remarkably versa-
tile bacterium. Some strains have been reported as plant-growth-
promoting rhizobacteria [3,6], and other can degrade environ-
mental pollutants [9,20,26]. P. aeruginosa is also an important
opportunistic pathogen and a major cause of serious nosocomial
infections [5,25,38], especially in immunocompromised patients
or patients with a predisposing condition [25,44]. Nevertheless,
P. aeruginosa also affects healthy individuals and is an etiologi-
cal agent to consider in the differential diagnosis of rapidly pro-
gressing community-acquired pneumonia [21,25]. Even though
this bacterium is not known to be a primary pathogen for non-
cystic fibrosis (CF) patients, McCallum et al. reported a case in
which a CF patient chronically colonized with an epidemic P.
aeruginosa strain cross-infected her non-CF parents [32]. These
observations and many others show that P. aeruginosa is capa-
ble of also affecting healthy immunocompetent individuals. 
Environmental P. aeruginosa isolates have been consid-
ered as potential biological control agents or inducers of sys-
temic acquired resistance [3,6,14], in bioremediation programs
[9,35], and in other applications [11,20]. Over the last 15 years
our group has developed several bacterial consortia for the
bioremediation of oil-derived hydrocarbons. Taking advantage
of the degradative properties of native microbiota, those con-
sortia have been used successfully in different contaminated
regions of Colombia (data not published) in which strains of P.
aeruginosa are naturally present. Several lines of evidence
strongly suggest that there are no major differences in viru-
lence between clinical and environmental isolates: clone and
pilin-type distributions of P. aeruginosa isolates were shown
to be the same in a group of strains from the environment as in
strains obtained from CF patients [29,40]. No differences were
found in selected pathogenicity determinants such as type-IV
pilin genes [42], flagellin genes [34], genes for multidrug
efflux systems and for the type III secretion system, the porin
gene oprD [36], hemolytic and proteolytic activities, and inva-
sion of epithelial cells [1]. Additionally, recent studies showed
that the genomes of clinical and environmental strains are
highly conserved [33,46]. All P. aeruginosa strains used for
bioremediation were isolated from the environment, but the
virulence of environmental P. aeruginosa strains has not yet
been tested in plant or animal models. 
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In the present study, we compared the virulence of clini-
cal and environmental P. aeruginosa isolates as determined
in two model hosts, the fruit fly Drosophila melanogaster
(animal model reported to be suitable to detect virulence dif-
ferences in P. aeruginosa strains) [13] and the plant Lactuca
sativa var. capitata L. (plant model widely accepted as a test
for bacterial pathogenicity) [15]. 
It is well-known that P. aeruginosa infections in humans
occur mainly in immunocompromised patients [25] and in
patients with a pre-existing disease or other predisposing
conditions [4,44]. However, reports of P. aeruginosa affect-
ing healthy individuals create additional concern about the
possible effects of bioaugmentation with P. aeruginosa pop-
ulations. In a literature survey of infections caused by P.
aeruginosa in healthy individuals, we found reports of P.
aeruginosa having caused an epidemic folliculitis in 117
people [17]; dermatitis in a healthy 27-year old man and two
other persons that used the same bathtub [10]; septicemia in
healthy children [47]; ecthyma gangrenosum and infection in
a child without known risk factors [39]; liver abscess in a
healthy child [31]; community-acquired sacro-iliitis in a
young, healthy man [8]; spread of P. aeruginosa from a CF
patient to healthy relatives [32]; community-acquired fatal
bacteraemia in two previously healthy patients [24], and
community-acquired pneumonia [21].
Materials and methods
Isolation and characterization of P. aeruginosa strains.
Clinical P. aeruginosa isolates were obtained from hospitals and medical
institutions from several cities in Colombia, South America (Table 1).
Environmental P. aeruginosa isolates were recovered from soil and water
samples by dilution and plating on cetrimide agar (Difco). Soil and water
samples were taken from locations considered to have a low risk of hospital
specimen contamination in order to ensure the non-clinical origin of the envi-
ronmental isolates. Samples were processed as follows: water samples were
serially diluted and plated, and an undiluted 0.1 ml aliquot was also plated. For
soils, 50-g soil samples were mixed with 50 ml of sterile water and shaken for
30 min. The resulting suspension was allowed to settle for 30 min and the
supernatant was serially diluted and plated. An undiluted 0.1.ml aliquot of the
supernatant was plated as well. Plates were incubated at 30°C for 48 h.
Isolates received from hospitals and those recovered on cetrimide plates
were maintained frozen at -80°C with glycerol. The 16S rRNA genes from
all the isolates were amplified by PCR (primer forward AGAGTTT
GATYMTGGC and reverse TACGGYTACCTTGTTACGA) [18]. The reac-
tion mixture contained 1.5 mM MgCl2, 0.2 mM dNTP, 0.1 mg of each primer
per ml, 2.5 U Taq polymerase, and 3 μl of crude extract obtained from an
overnight culture as the DNA source. Reaction conditions were 94ºC for 3
min, 25 cycles of 94ºC for 45 s, 50ºC for 45 s, 72ºC for 45 s, and a final exten-
sion of 72ºC for 7 min. Amplification products were purified and sequenced
by the Micro Core Facility at Harvard Medical School, Boston, MA, USA.
Sequences were blasted against the National Center for Biotechnology
Information (NCBI) database [2]. Only the strains whose 16S rRNA
sequence showed >99% identity to published P. aeruginosa sequence were
used for subsequent assays.
For the pathogenesis assays, ten isolates of P. aeruginosa (five from clin-
ical sources and five from environmental sources) were chosen (Table 1).
Biochemical tests were done using the API 20NE strips kit (BioMérieux,
France) according to the manufacturer’s instructions. The Espinosa Gómez
Laboratory (Bogotá, Colombia) used the Kirby-Bauer disc diffusion method
to detect the antibiotic susceptibility pattern of P. aeruginosa strain 6E [23].
For the other nine strains, antibiotic susceptibility tests were carried out by Dr.
Clara Luz Rico, at the Microbiology Laboratory from Fundación Santa Fe de
Bogotá (Bogotá, Colombia), using the Vitek 2 automatized microdilution
method (BioMérieux, France) [16]. Biochemical and antimicrobial suscepti-
bility characteristics were analyzed with the software PAUP* [Swofford DL
(2002) PAUP*: Phylogenetic Analysis Using Parsimony (and other methods)
4.0 b10; Sinauer Associates, Sunderland, MA], searching for clusters of the
strains according to their origin. Two P. aeruginosa PA01 strains (donated by
Deborah Hogan from Harvard Medical School, Boston, MA, USA) served as
virulent positive controls; a native strain of P. putida was the negative control.
Pathogenesis assay in D. melanogaster. P. aeruginosa strains
were grown overnight on nutrient agar plates at 30°C. For each strain, a bac-
terial suspension was prepared in sterile saline solution (NaCl 0.85%) and
adjusted to a McFarland turbidity standard of 0.5 (1 ×108 colony forming
units [cfu]/ml) [23]. Five adult female wild-type flies (supplied by Marina
Ordóñez, Instituto de Genética de Poblaciones, Los Andes University) 2–4
days old were pricked in the dorsal thorax with a sterile needle that had been
dipped into a P. aeruginosa isolate suspension [13]. Flies were returned to
standard fly culture vials with food, and survival percentage at 16, 22, 25,
28, 30, 32 and 40 h after inoculation was recorded. The experiments consist-
ed of three replicas per strain and were repeated twice. Negative controls for
all experiments were done by pricking the flies with a needle dipped into
sterile saline solution; an additional negative control was done by pricking
the flies with a needle dipped into a suspension of P. putida strain M2A (iso-
lated in this study) prepared in the same way as described for the P. aerugi-
nosa strains. Controls were cultured as described above.
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Tabla 1. Clinical (C) and environmental (E) Pseudomonas aeruginosa isolates used in pathogenesis assays
Isolate Origin* NCBI database 16S rRNA
(>99% similarity)
Accession
number
1C
2C
3C
4C
5C
6E
7E
8E
9E
10E
Post-operative infection (Clín. del Prado, Santa Marta)
Urinary-tract infection (Fund. Hosp. de la Misecordia, Bogotá)
Catheter (Hosp. Kennedy, Bogotá)
Post-operative infection (Hosp. Federico Lleras Acosta, Ibagué)
Septicemia (Hosp. Federico Lleras Acosta, Ibagué)
Soil (Villeta, Cundinamarca)
Oil-contaminated water (Caño Limón, Arauca)
Oil-contaminated water (Caño Limón, Arauca)
Oil-contaminated water (Caño Limón, Arauca)
Oil-contaminated soil (Capachos, Arauca)
P. aeruginosa SCD-13
P. aeruginosa SCD-13
P. aeruginosa SCD-1
P. aeruginosa SCD-13
P. aeruginosa SCD-13
P. aeruginosa SCD-13
P. aeruginosa SCD-13
P. aeruginosa SCD-13
P. aeruginosa SCD-13
P. aeruginosa SCD-13
AF448036
AF448036
AF448038
AF448036
AF448036
AF448036
AF448036
AF448036
AF448036
AF448036
*All locations are in Colombia.
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Pathogenesis assay in Lactuca sativa var. capitata L. Each
P. aeruginosa strain was grown on LB broth to 2 ×109 cfu/ml. From the cul-
ture, a 1-ml sample was withdrawn, centrifuged twice, and resuspended in
sterile saline solution. Serial dilutions of the final suspension were plated to
determine viable counts, and 5 μl was inoculated into leaf segments of
healthy plants of L. sativa var. capitata L acquired in local supermarkets.
Leaves were detached and disinfected by washing them sequentially with tap
water, 1% sodium hypochlorite, sterile distilled water, 70% ethanol, and
sterile distilled water. Once disinfected, circular 2.5-cm leaf segments were
cut out under sterile conditions. Individual segments were placed onto ster-
ile Petri dishes and inoculated with 5 μl of the bacterial suspension, prepared
as described before. Inoculated leave segments were incubated at 30°C for 3
days in a humid chamber to avoid desiccation of the segments [15]. Lower
doses of 1 × 106, 1 × 104, and 1 × 102 cfu were also tested. The diameter of
the lesion was recorded daily. The experiments, consisting of two replicas
per strain, were repeated three times. Negative controls for all experiments
were done by inoculating leaf segments with sterile saline solution; addition-
al negative controls consisted of leaf segments inoculated with a 5-μl sus-
pension of P. putida strain M2A prepared as described for the P. aeruginosa
strains. Controls were cultured in the same conditions as the inoculated
experimental samples.
Statistical analysis. The normal distribution of the resulting data from
the pathogenicity assays, with both the fruit fly and the lettuce model, was
tested with the Shapiro-Wilk normality test, a standard test for small sample
sizes. For this test, a small P-value indicates a non-normal distribution of the
data with high significance. Results obtained from the clinical and environ-
mental isolates were compared using the nonparametric Wilcoxon rank sum
and Kruskal-Wallis tests [41]. These tests evaluate whether unpaired sam-
ples come from the same population (null hypothesis), with the null hypoth-
esis rejected at P < 0.05. All tests were carried out using Statistix 8.0 or
SPSS 7.5 software. Distribution of the data was diagramed with SPSS 7.5.
Results 
Isolation of P. aeruginosa from environmental
samples. Of the 38 water and soil samples analyzed (9 oil-
contaminated and 29 non-oil-contaminated), 50 isolates were
recovered on cetrimide plates. Of these, 19 were identified as
P. aeruginosa, corresponding to 38% of the total isolates. The
other 31 isolates belonged to different pseudomonads species
(P. putida, P. fluorescens, P. stutzeri) or to other genera of
gram-negative bacteria. Note that of the 19 P. aeruginosa iso-
lates, 16 were found in samples contaminated with oil hydro-
carbons; P. aeruginosa was recovered from all nine oil-con-
taminated samples, but only from three non-oil-contaminated
samples (corresponding to 10.3%).
Parsimony analysis using biochemical and antimicrobial
susceptibility characteristics did not group the strains accord-
ing to the source (data not shown), indicating that environ-
mental and clinical strains cannot be differentiated by means
of these characteristics.
Pathogenesis in the D. melanogaster model
testing clinical and environmental P. aerugi-
nosa isolates. Both groups of isolates killed the flies irre-
spective of the source of the bacteria. The distribution of the
data for the time points 16, 25, 30 and 40 h post-inoculation
is shown in Fig. 1. Only one strain, isolate 6E, was particu-
larly less virulent than any of the other strains (data not
shown). The results did not show a normal distribution for
the different time points evaluated (non-normal distribution
accepted at P < 0.05; Shapiro-Wilk test at 16 h after inocula-
tion N: 54, W: 0.5422, P < 0.001; at 22 h after inoculation
N60, W: 0.7655, P < 0.001; 25 h after inoculation N60, W:
0.8775, P < 0.001; 28 h after inoculation N54, W: 0.9160, P
< 0.0011; 30 h after inoculation N45, W: 0.9176, P: 0.0035;
32 h after inoculation N60, W: 0.8522, P < 0.001; 40 h after
inoculation N60, W: 0.6090, P < 0.001). The survival of ani-
mals at the end of the experiment (40 h post-inoculation) was
the same for both groups of strains, clinical and environmen-
tal (Fig. 1; Wilcoxon rank sum test at 40 h after inoculation
N60, two-tailed P-value 0.7145; Kruskal-Wallis test 40 h
after inoculation N60, KW: 0.1402, P: 0.7081). The results at
different times after inoculation were analyzed to detect pos-
sible differences in the course of infection between the two
groups of strains, but again no significant difference in fly
survival was found (Wilcoxon rank sum test at 16 h after
inoculation [ai] N54, two-tailed [tt] P-value 0.9648; at 22 h
ai N60, tt P-value 0.4531; at 25 h ai N60, tt P-value 0.7173;
at 28 h ai N54, tt P-value 0.5487; at 30 h ai N45, tt P-value
0.7321; at 32 h ai N60, tt P-value 0.9757. Kruskal-Wallis test
at 16 h ai N54, KW: 0.003, P: 0.956; 22 h ai N60, KW:
0.5747, P: 0.4484; 25 h ai N60, KW: 0.1366, P: 0.7116; 28 h
ai N54, KW: 0.3703, P: 0.5428; 30 h ai N45, KW: 0.1258, P:
0.7229; 32 h ai N60, KW: 0.0014, P: 0.9697). The survival
of controls inoculated with either P. putida M2A or sterile
saline was 93–100% for all experiments. 
Pathogenesis in L. sativa var. capitata L. for cli-
nical and environmental P. aeruginosa isolates.
Both groups of isolates produced similar necrotic lesions irre-
spective of their origin (Fig. 2) with the exception of strain 6E,
which produced smaller lesions than all other strains. The
results did not show a normal distribution (Shapiro-Wilk test at
72 h after inoculation N: 52, W: 0.8986, P < 0.0003). No sig-
nificant differences were found in the diameter of the lesions
of the two groups (Wilcoxon rank rum test N52, two-tailed
P-value: 0.1078; Kruskal-Wallis test N52, KW: 2.6165, P:
0.1058). Leaf segments inoculated with P. putida M2A.1
showed either no lesions or a small yellow zone at the inocu-
lation site. Lesions did not form on any of the leaf segments
inoculated with sterile saline solution. At lower doses (1 × 106,
1 × 104 and 1 × 102 cfu) no differences were found in the diam-
eters of any of the lesions between the two groups of isolates,
clinical and environmental (for 1 × 106 cfu dose Kruskal-Wallis
test [dKWt] N28: 0.105, P: 0,746; for 1 × 104 cfu dKWt N27:
0.144, P: 0.705; for 1 × 102 cfu dKWt N27: 0.204, P: 0.651).
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Discussion
P. aeruginosa strains were recovered from all oil-contaminated
samples, but only from 10.3% of the non-oil-contaminated
ones. This result was surprising, since P. aeruginosa is consid-
ered to be ubiquitous [20,27]. Our results showing that P.
aeruginosa thrives in oil-contaminated niches agree with previ-
ous reports regarding its degradative capabilities [9,20].
However, the bacterium has fewer growth advantages in non-
oil-contaminated ecosystems. Thus, it is possible that P. aerug-
inosa populations for the 23 P. aeruginosa-negative samples
were present but not detectable by the dilution technique.
P. aeruginosa strains have been previously isolated from
environmental samples. Green et al. [19] isolated P. aerugi-
nosa strains from 14 of 58 (24%) agricultural soil samples.
Jacobsen et al. [22] reported an initially non-detectable pop-
ulation of P. aeruginosa (<100 cells per g soil) in a
trichloroethylene-contaminated soil sample from Denmark.
Kimata et al. [27] found that P. aeruginosa is part of the
indigenous microbiota of the seawater in Tokyo Bay. They
found important differences between the two enumeration
techniques used to detect the bacterium. The direct viable
count-fluorescent antibody technique yielded 102–104
cells/ml whereas culture counts were 0.17–0.72 cells/ml,
indicating that P. aeruginosa can survive in a viable but not
culturable state. This observation could explain, at least par-
tially, the low recovery efficiency of P. aeruginosa from soil
and water. However, the low counts of P. aeruginosa can
quickly increase when an external factor affects the environ-
ment and the bacterium has an advantage over the microbial
population, a survival strategy known as zymogenous [30].
This was the case in the Danish study mentioned above, in
which the initial count of < 100 cells P. aeruginosa/g soil
increased dramatically to 105 cells/g after steam treatment
but decreased rapidly afterwards [22]. Although “zymoge-
nous” refers to the stimulation of microbial activity by sub-
strates, other conditions, such as a reduction of competitors
can also stimulate proliferation [22].
P. aeruginosa has been described as a common inhabitant of
sewage and large populations persist even after anaerobic treat-
ment of the sewage. Benatti et al. [7] reported P. aeruginosa
populations of 105 most probable number (MPN) per ml in the
influent sludge of a municipal anaerobic digestor, and 104
MPN/ml in the effluent sludge. Curran et al. [12] found even
higher numbers on the surface of mushrooms sampled at super-
markets in five European countries (104–107 cfu/g); some sam-
ples of the compost used for growing the mushrooms also
carried 107 cfu of P. aeruginosa/g. A natural source of P.
aeruginosa could be mammalian feces, but previous work
showed that a low percentage (3–6%) of the healthy human
population carries the bacterium fecally [28]. More recently,
Pirnay et al. [37] reported a positive relationship between the
extent of pollution in a Belgian river and the prevalence of P.
aeruginosa. Our results indicating that P. aeruginosa is more
successful in oil-contaminated environments suggest that this
species is a poor competitor in undisturbed environments, but
thrives and is able to rapidly grow when the appropriate
nutrients become available or conditions are otherwise favor-
able (e.g., reduced microbiota). 
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Fig. 1. Time course of survival of Drosophila melanogaster after inoculation
with clinical and environmental Pseudomonas aeruginosa isolates. 
Fig. 2. Lesion diameter on Lactuca sativa var. capitata L. leaf segments after
inoculation with clinical and environmental P. aeruginosa isolates. Box and
whiskers representation of the diameters of the lesions obtained from exper-
iments in which L. sativa var. capitata L. leaves were inoculated with 1 × 107
cfu from each of five clinical and five environmental strains of the bacteri-
um. Boxes indicate the middle 50% of the data (interquartile range); the dark
horizontal lines represent the median values, and the vertical lines extend to
the smallest and largest values of the distribution. Open circles represent out-
liers. Note that medians are the same for the two groups, and the distribution
of the data overlap.
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Results from the two models used in this study did not dif-
fer with respect to the virulence of clinical and environmental
isolates of P. aeruginosa. In addition, the antibiotic resistance
profiles were almost exactly the same for all strains tested
(MAR index: 0.5–0.6, data not shown). This finding clearly
indicates that it is a mistake to consider environmental strains
safer than clinical ones. For bioremediation purposes, environ-
mental isolates are augmented and reintroduced into the pollut-
ed region, in a practice known as bioaugmentation [43], in
which the bacterial population is increased 100- to 1000-fold
in order to enhance bioremediation. According to the evidence
presented here, this practice involving P. aeruginosa strains
poses a serious threat to susceptible hosts, since P. aeruginosa
is known to affect a wide variety of organisms, such as insects
[13], nematodes [38], plants [38,45], birds [5], and mammals
including humans [25]. With this broad range of potential
hosts, the introduction of high populations of P. aeruginosa
into the environment may represent a putative risk to wild life
inhabiting locations where bioremediation will be applied.
Moreover, it may be hazardous to people who might, unknow-
ingly, enter the zone under treatment. Additional studies in
other animal models (i.e., mice, rats, rabbits) are necessary to
reach more definitive conclusions about possible threats to
humans and animals.
The results of the two models chosen for this study were
similar, but the assay with lettuce leaves is faster and easier.
Only strains proven to be less virulent in the pathogenicity
assay should be applied for bioremediation. If this is not pos-
sible, containment measures should be taken and a complete
set of industrial safety regulations implemented for the
appropriate use of virulent but nonetheless useful strains.
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Comparación de la virulencia entre aislados
clínicos y ambientales de Pseudomonas
aeruginosa
Resumen. Para caracterizar la virulencia del patógeno oportunista Pseu-
domonas aeruginosa, se aislaron nuevas cepas a partir de muestras clínicas
y ambientales. P. aeruginosa se recuperó con una elevada frecuencia a par-
tir de muestras contaminadas con petróleo, mientras que la frecuencia de
recuperación a partir de muestras no contaminadas fue muy baja. La virulen-
cia de cinco cepas ambientales y cinco cepas clínicas de P. aeruginosa se
evaluó usando dos modelos diferentes, Drosophila melanogaster y Lactuca
sativa var. capitata L. No se encontraron diferencias en la virulencia de los
dos grupos de aislados con ninguno de los modelos. Dado que en procesos
de biorremediación y bioaumento se usan cepas ambientales de P. aerugino-
sa, estos resultados deberían tenerse en cuenta en el futuro diseño de consor-
cios degradadores y para establecer las medidas de seguridad necesarias para
su utilización. [Int Microbiol 2006; 9(4):247-252]
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Comparação da virulência entre isolados
clínicos e ambientais de Pseudomonas
aeruginosa
Resumo. Para caracterizar a virulência do patógeno oportunista Pseudo-
monas aeruginosa, forma isoladas novas cepas a partir de amostras clínicas
e ambientais. P. aeruginosa foi recuperada a freqüências elevadas a partir de
amostras contaminadas com petróleo e lodos oleosos, enquanto a freqüência
de recuperação a partir de amostras não contaminadas foi muito baixa.
Avaliou-se a virulência de cinco linhagens ambientais e cinco linhagens
clínicas de P. aeruginosa usando dois modelos diferentes, Drosophila me-
lanogaster e Lactuca sativa var. capitata L. Os resultados não mostraram
diferenças na virulência dos dois grupos de isolados com nenhum dos mo-
delos. Dado que em processos de biorremédio e bioaumento se usam lin-
hagens ambientais de P. aeruginosa, deveriam ter-se em conta estes resulta-
dos no futuro desenho de consórcios degradativos e nas medidas de segu-
rança necessárias para sua utilização. [Int Microbiol 2006; 9(4):247-252]
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